Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines



   tay-sachs disease
  

Disease ID 106
Disease tay-sachs disease
Definition
An autosomal recessive neurodegenerative disorder characterized by the onset in infancy of an exaggerated startle response, followed by paralysis, dementia, and blindness. It is caused by mutation in the alpha subunit of the HEXOSAMINIDASE A resulting in lipid-laden ganglion cells. It is also known as the B variant (with increased HEXOSAMINIDASE B but absence of hexosaminidase A) and is strongly associated with Ashkenazic Jewish ancestry.
Synonym
b variant gm2 gangliosidosis
b variant gm2-gangliosidoses
b variant gm2-gangliosidosis
defic dis hexosaminidase a
deficiency disease hexosaminidase a
deficiency hexosaminidase
disease sach tay
disease sach's tay
disease sachs tay
disease tay sach
disease tay sachs
disease tay-sachs
disease, tay-sachs
diseases sachs tay
diseases sachs tays
diseases tay sachs
g(m2) gangliosidosis, type i
gangliosidosis g(m2), type i
gangliosidosis gm 02 b variant
gangliosidosis gm 02 type i
gangliosidosis gm2 , type 1
gangliosidosis gm2 type 1
gangliosidosis gm2 type i
gangliosidosis gm2, b variant
gangliosidosis gm2, type i
gm gangliosidosis 02 type i
gm2 gangliosidosis type i
gm2 gangliosidosis, b variant
gm2 gangliosidosis, type 1
gm2 gangliosidosis, type i
gm2-gangliosidosis, b variant
gm2-gangliosidosis, type i
gm2 gangliosidosis, type 1
gm>2< gangliosidosis, type 1
hexa deficiency
hexosaminidase a defic dis
hexosaminidase a deficiency
hexosaminidase a deficiency disease
infantile ganglioside lipidosis
lipidosis, ganglioside, infantile
severe hexosaminidase a deficiency
sphingolipidosis, tay sachs
sphingolipidosis, tay-sachs
tay sach's disease
tay sachs dis
tay sachs disease
tay sachs disease, b variant
tay-sachs disease (disorder)
tay-sachs disease [disease/finding]
tay-sachs disease, b variant
tay-sachs sphingolipidosis
tsd
type i gm2-gangliosidosis
Orphanet
OMIM
DOID
ICD10
UMLS
C0039373
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:3)
C0236642  |  pick disease  |  2
C0028064  |  niemann-pick disease  |  2
C0023522  |  metachromatic leukodystrophy  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:2)
HEXA  |  3073  |  CLINVAR;CTD_human;UNIPROT;GHR
GM2A  |  2760  |  CLINVAR
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:2)
3073  |  HEXA  |  infer
3074  |  HEXB  |  infer
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:60)
4074  |  M6PR  |  DISEASES
8935  |  SKAP2  |  DISEASES
410  |  ARSA  |  DISEASES
7942  |  TFEB  |  DISEASES
7903  |  ST8SIA4  |  DISEASES
4759  |  NEU2  |  DISEASES
3425  |  IDUA  |  DISEASES
53  |  ACP2  |  DISEASES
3832  |  KIF11  |  DISEASES
3074  |  HEXB  |  DISEASES
57679  |  ALS2  |  DISEASES
3371  |  TNC  |  DISEASES
4986  |  OPRK1  |  DISEASES
4885  |  NPTX2  |  DISEASES
3073  |  HEXA  |  DISEASES
5428  |  POLG  |  DISEASES
285362  |  SUMF1  |  DISEASES
3087  |  HHEX  |  DISEASES
10825  |  NEU3  |  DISEASES
178  |  AGL  |  DISEASES
2548  |  GAA  |  DISEASES
2720  |  GLB1  |  DISEASES
4884  |  NPTX1  |  DISEASES
6620  |  SNCB  |  DISEASES
51228  |  GLTP  |  DISEASES
64231  |  MS4A6A  |  DISEASES
274  |  BIN1  |  DISEASES
4351  |  MPI  |  DISEASES
129807  |  NEU4  |  DISEASES
8706  |  B3GALNT1  |  DISEASES
23467  |  NPTXR  |  DISEASES
80789  |  INTS5  |  DISEASES
10871  |  CD300C  |  DISEASES
5367  |  PMCH  |  DISEASES
5521  |  PPP2R2B  |  DISEASES
1798  |  DPAGT1  |  DISEASES
3476  |  IGBP1  |  DISEASES
3482  |  IGF2R  |  DISEASES
2760  |  GM2A  |  DISEASES
280  |  AMY2B  |  DISEASES
10724  |  MGEA5  |  DISEASES
55157  |  DARS2  |  DISEASES
5730  |  PTGDS  |  DISEASES
5476  |  CTSA  |  DISEASES
229  |  ALDOB  |  DISEASES
4758  |  NEU1  |  DISEASES
54840  |  APTX  |  DISEASES
26278  |  SACS  |  DISEASES
2706  |  GJB2  |  DISEASES
8301  |  PICALM  |  DISEASES
5660  |  PSAP  |  DISEASES
174  |  AFP  |  DISEASES
4668  |  NAGA  |  DISEASES
85300  |  ATCAY  |  DISEASES
2632  |  GBE1  |  DISEASES
643680  |  MS4A4E  |  DISEASES
51366  |  UBR5  |  DISEASES
3748  |  KCNC3  |  DISEASES
4850  |  CNOT4  |  DISEASES
2108  |  ETFA  |  DISEASES
Locus(Waiting for update.)
Disease ID 106
Disease tay-sachs disease
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:32)
HP:0009058  |  Increased muscle lipid content
HP:0001263  |  Global developmental delay
HP:0002353  |  EEG abnormality
HP:0004374  |  Hemiplegia/hemiparesis
HP:0002361  |  Psychomotor deterioration
HP:0002361  |  Psychomotor degeneration
HP:0001251  |  Ataxia
HP:0001252  |  Hypotonia
HP:0001744  |  Splenomegaly
HP:0001250  |  Seizures
HP:0002267  |  Exaggerated startle response
HP:0000618  |  Blindness
HP:0000365  |  Hearing impairment
HP:0001257  |  Spasticity
HP:0001252  |  Muscular hypotonia
HP:0002376  |  Developmental regression
HP:0002240  |  Hepatomegaly
HP:0010729  |  Macular cherry red spot
HP:0000505  |  Visual impairment
HP:0000726  |  Dementia
HP:0006887  |  Intellectual disability, progressive
HP:0000256  |  Macrocephaly
HP:0003495  |  GM2-ganglioside accumulation
HP:0002421  |  Poor head control
HP:0001347  |  Hyperreflexia
HP:0002205  |  Recurrent respiratory infections
HP:0000741  |  Apathy
HP:0002835  |  Aspiration
HP:0100022  |  Abnormality of movement
HP:0000648  |  Optic atrophy
HP:0010729  |  Cherry red spot of the macula
HP:0002486  |  Myotonia
Text Mined Phenotype(Waiting for update.)
Disease ID 106
Disease tay-sachs disease
Manually Symptom
UMLS  | Name(Total Manually Symptoms:1)
C0036161  |  o variant
Text Mined Symptom(Waiting for update.)
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:52)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs121907952NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572345528CT
rs121907954NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572350518CT
rs121907957NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572353129CT
rs121907958NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572346597CG
rs121907960NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572349153GAA-
rs121907961NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572351176GA
rs121907962NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572355562GA
rs121907963NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572346680GA
rs121907964NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA;HEXA-AS11572375895CT
rs121907965NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA;HEXA-AS11572375972TG,C
rs121907966NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572345477GA
rs121907968NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572345519AG
rs121907969NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572353098GC,A
rs12190797013843233073HEXAumls:C0039373BeFreeWe analyzed the HEXA gene of one pseudodeficient subject and identified both a C739-to-T substitution that changes Arg247----Trp on one allele and a previously identified Tay-Sachs disease mutation on the second allele.0.4706604571992HEXA1572350584GA
rs121907972NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572353130GA
rs121907974NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572351173AG
rs121907975NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572355591AC
rs121907976NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572351194TC
rs121907977NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572349163AC
rs121907978NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572346296CT
rs121907979NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA;HEXA-AS11572375857AC
rs147324677NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572346234CG
rs180042918257923073HEXAumls:C0039373UNIPROTThe biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis.0.4706604571991HEXA1572351207CT
rs180042990905233073HEXAumls:C0039373UNIPROTTay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.0.4706604571997HEXA1572351207CT
rs199578185145664833073HEXAumls:C0039373UNIPROTDifferent attenuated phenotypes of GM2 gangliosidosis variant B in Japanese patients with HEXA mutations at codon 499, and five novel mutations responsible for infantile acute form.0.4706604572003HEXA1572349181TC
rs200926928NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572349076TC
rs267606862NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572346681CT
rs28940871NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572346305GC
rs2894177090905233073HEXAumls:C0039373UNIPROTTay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.0.4706604571997HEXA1572353105CT,G,A
rs2894177018257923073HEXAumls:C0039373UNIPROTThe biochemistry of HEXA and HEXB gene mutations causing GM2 gangliosidosis.0.4706604571991HEXA1572353105CT,G,A
rs28941770NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572353105CT,G,A
rs2894177187570363073HEXAumls:C0039373UNIPROTLate-onset GM2 gangliosidosis is a variant form of Tay-Sachs disease characterized by onset of symptoms and signs in adolescence or in early adult life.0.4706604571996HEXA1572353100AG
rs2894207118372833073HEXAumls:C0039373UNIPROTTotal RNA was isolated from cultured fibroblasts from 12 unrelated patients with Tay-Sachs disease, an autosomal recessive disorder due to beta-hexosaminidase A deficiency. beta-Hexosaminidase mRNA was amplified by cDNA-PCR in four overlapping segments spanning the entire coding sequence.0.4706604571991HEXA1572345462GA
rs28942071NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572345462GA
rs370266293NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572346679CT
rs387906309NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572346579-GATA
rs387906949NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA;HEXA-AS11572375800CT,A
rs587779405NA2760GM2Aumls:C0039373CLINVARNA0.120542884NAGM2A5151266820C-
rs587779406NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572346552GA
rs587779407NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572350604-A
rs748190164NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572356531CG
rs76173977NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572348047CT
rs766138785NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572347709C-
rs770932296NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572349266CT
rs777042785NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572346549TA-
rs778155650NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572349148AAG-
rs786204515NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572349117-T
rs786204585NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572344139GA
rs786204721NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA;HEXA-AS11572375971AG
rs786204754NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572353067CT
rs797044432NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572356524CG
rs797044433NA3073HEXAumls:C0039373CLINVARNA0.470660457NAHEXA1572345462G-
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:1)
HP ID HP Name MP ID MP Name Annotation
HP:0001252Muscular hypotoniaMP:0004144hypotonia;HP:0100022Abnormality of movement
Mapped by homologous gene(Total Items:1)
HP ID HP Name MP ID MP Name Annotation
HP:0004374Hemiplegia/hemiparesisMP:0000010abnormal abdominal fat pad morphology;HP:0002311Incoordination
Chemical(Total Drugs:0)
(Waiting for update.)
FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)
FDA labeling changes(Total Drugs:0)
(Waiting for update.)